Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Linden Lake Venture Capital is a venture capital firm dedicated to founding, building, and investing in biotechnology companies that develop new molecular medicines. Established with a strong foundation in biotechnology and medical knowledge, the firm combines legal acumen and private equity investment experience to address the pressing needs of patients requiring transformative treatments. The organization has a history of entrepreneurial success in the biotechnology sector, positioning it as a significant player in early-stage investments.
Currently, Linden Lake focuses on early-stage investments, particularly in pre-seed, seed, and Series A rounds. The firm has a targeted approach within the biotechnology sector, emphasizing innovative therapeutic modalities and personalized medicine. Their portfolio includes notable companies such as Vesigen Therapeutics and AexeRNA Therapeutics, showcasing their commitment to impactful investments. The firm operates with a clear mission to enhance healthcare solutions through biotechnology.
Linden Lake Venture Capital invests primarily in early-stage biotechnology companies, particularly those engaged in pre-clinical and phase I technologies. Their investment strategy encompasses several focus areas, including novel therapeutic biologics, gene/nucleic acid-based therapies, cell/regenerative therapies, and therapeutic modality optimization platforms aimed at personalized medicine. This targeted approach allows them to address the unique challenges and opportunities within the biotechnology landscape.
The firm seeks to partner with companies that are developing innovative therapeutic modalities, particularly those that leverage advanced genomics and bioinformatics for tailored medical interventions. Linden Lake's emphasis on transformative treatments aligns with their goal of improving patient outcomes through cutting-edge biotechnology solutions. They look for founders who demonstrate a strong vision and capability to navigate the complexities of the biotech industry.
Linden Lake Venture Capital's portfolio includes several notable companies that exemplify their focus on biotechnology innovation:
Thomas Axel Haag, Ph.D., J.D. - Managing Partner. Thomas has a strong background in biotechnology and law, combining his expertise to lead investments in innovative biotech companies. His experience includes significant roles in private equity and venture capital, focusing on early-stage biotechnology investments.
Submit your pitch through their website's contact form for consideration.
In October 2023, AexeRNA Therapeutics, a portfolio company of Linden Lake Venture Capital, was acquired by BioNTech SE. This acquisition marks a notable exit for the firm and highlights its successful investment strategy in the biotechnology sector.
What are Linden Lake's investment criteria?
Linden Lake Venture Capital focuses on early-stage biotechnology companies, particularly those engaged in pre-clinical and phase I technologies. They seek innovative therapeutic modalities and personalized medicine solutions that address significant patient needs.
How can startups apply or pitch to Linden Lake?
Startups interested in pitching to Linden Lake can complete a webform on their website. Specific details regarding the pitch deck or application process are not publicly disclosed.
What makes Linden Lake different from other venture capital firms?
Linden Lake combines expertise in biotechnology, medical knowledge, legal acumen, and private equity investment experience, allowing them to provide unique insights and support to their portfolio companies.
What is the geographic scope of Linden Lake's investments?
The firm primarily invests in biotechnology companies, but specific geographic preferences are not detailed in the available information.
What is Linden Lake's post-investment involvement like?
While specific details on post-investment involvement are not provided, the firm emphasizes its commitment to building and supporting innovative biotechnology companies, suggesting active engagement with portfolio companies.
What is the typical check size for investments?
Specific check sizes are not disclosed, but Linden Lake focuses on early-stage investments, which typically range from pre-seed to Series A funding rounds.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.